Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Nanette C. Schloot, Magaly Perez-Nieves, Hélène Sapin, Silvia Kruppert, Thorsten Otto, Sheila M. Corrigan & Carolina Piras de Oliveira. (2020) Patient characteristics of insulin lispro 200 units/mL users in real world setting in Germany. Current Medical Research and Opinion 36:10, pages 1611-1617.
Read now
Read now
Oppel Bw Greeff, Jacob John van Tonder, Kershlin Naidu, Alicia McMaster, Alet van Tonder & Rashem Mothilal. (2018) A practical guide to the interpretation of PK/PD profiles of longer-acting analogue insulins. Part two: Insulin degludec vs. insulin glargine U300. Journal of Endocrinology, Metabolism and Diabetes of South Africa 23:2, pages 46-51.
Read now
Read now
Fernando Ovalle, Alissa R. Segal, John E. Anderson, Michael R. Cohen, Tina M. Morwick & Jeffrey A. Jackson. (2018) Understanding concentrated insulins: a systematic review of randomized controlled trials. Current Medical Research and Opinion 34:6, pages 1029-1043.
Read now
Read now
Sarah L. Anderson, Jennifer M. Trujillo, John E. Anderson & Robert J. Tanenberg. (2018) Switching basal insulins in type 2 diabetes: practical recommendations for health care providers. Postgraduate Medicine 130:2, pages 229-238.
Read now
Read now
Oppel BW Greeff, Jacob John van Tonder, Kershlin Naidu, Alicia McMaster, Alet van Tonder & Rashem Mothilal. (2018) A practical guide to the interpretation of PK/PD profiles of longer-acting analogue insulins. Part one: The principles of glucose clamp studies. Journal of Endocrinology, Metabolism and Diabetes of South Africa 23:1, pages 17-21.
Read now
Read now
Timothy S. Reid, Fryn Schafer & Cynthia Brusko. (2017) Higher concentration insulins: an overview of clinical considerations. Postgraduate Medicine 129:5, pages 554-562.
Read now
Read now
Elizabeth Mary Lamos & Stephen N. Davis. (2016) Pharmacokinetic evaluation of fixed-ratio combination of insulin degludec and liraglutide in the treatment of type 2 diabetes. Expert Opinion on Drug Metabolism & Toxicology 12:10, pages 1225-1232.
Read now
Read now
Articles from other publishers (6)
Sujoy Ghosh & Romik Ghosh. (2020) Glargine-300: An updated literature review on randomized controlled trials and real-world studies. World Journal of Diabetes 11:4, pages 100-114.
Crossref
Crossref
Lila S. Chertman, Danielle Neuman & Francesco Vendrame. 2020. Behavioral Diabetes. Behavioral Diabetes
261
275
.
Neng Chun Yu. (2019) Nocturnal Glycemic Control with New Insulin Glargine 300 U/mL. Advances in Medicine 2019, pages 1-6.
Crossref
Crossref
A. K. J. Gradel, T. Porsgaard, J. Lykkesfeldt, T. Seested, S. Gram-Nielsen, N. R. Kristensen & H. H. F. Refsgaard. (2018) Factors Affecting the Absorption of Subcutaneously Administered Insulin: Effect on Variability. Journal of Diabetes Research 2018, pages 1-17.
Crossref
Crossref
Courtney S. Davis, Joshua W. Fleming, Scott S. Malinowski, Meagan A. Brown & Laurie W. Fleming. (2018) Ultra-long-acting insulins: A review of efficacy, safety, and implications for practice. Journal of the American Association of Nurse Practitioners 30:7, pages 373-380.
Crossref
Crossref
Susan Shapiro Braithwaite, Dharmesh B. Bavda, Thaer Idrees, Faisal Qureshi & Oluwakemi T. Soetan. (2017) Hypoglycemia Reduction Strategies in the ICU. Current Diabetes Reports 17:12.
Crossref
Crossref